<DrugInformationSummary id="CDR0000495782"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>This page contains brief information about dasatinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/dasatinib">Dasatinib</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000315885">dasatinib</TerminologyLink><GlossaryLink ref="CDR0000484435">dasatinib</GlossaryLink><USBrandNames><USBrandName>Sprycel</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>da-SA-tih-nib</TermPronunciation><MediaLink ref="CDR0000716719" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000716718" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4764f37b-c9e6-4ede-bcc2-8a03b7c521df&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Dasatinib</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4764f37b-c9e6-4ede-bcc2-8a03b7c521df&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Dasatinib is approved to treat:</Para><ItemizedList Style="bullet" id="_4"><ListItem><Strong><GlossaryTermRef href="CDR0000045586" dictionary="Cancer.gov" audience="Patient">Acute lymphoblastic leukemia</GlossaryTermRef></Strong> that is <GlossaryTermRef href="CDR0000044179" dictionary="Cancer.gov" audience="Patient">Philadelphia chromosome</GlossaryTermRef> <GlossaryTermRef href="CDR0000044710" dictionary="Cancer.gov" audience="Patient">positive</GlossaryTermRef>. It is used:<ItemizedList Style="bullet" id="_6"><ListItem>In children aged 1 year or older with newly-diagnosed cancer.  It is used with other chemotherapy drugs.</ListItem><ListItem>In adults whose disease did not respond to other drugs or who are  not able to receive other drugs.</ListItem></ItemizedList>  </ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000044901" dictionary="Cancer.gov" audience="Patient">Chronic myelogenous leukemia</GlossaryTermRef></Strong> (CML) that is Philadelphia chromosome positive. It is used:<ItemizedList Style="bullet" id="_5"><ListItem>In children aged 1 year or older with <GlossaryTermRef href="CDR0000045160" dictionary="Cancer.gov" audience="Patient">chronic phase CML</GlossaryTermRef>.</ListItem><ListItem>In adults with chronic phase CML that is newly diagnosed.</ListItem><ListItem>In adults with chronic phase, <GlossaryTermRef href="CDR0000046212" dictionary="Cancer.gov" audience="Patient">accelerated phase</GlossaryTermRef>, or <GlossaryTermRef href="CDR0000046113" dictionary="Cancer.gov" audience="Patient">blastic phase CML</GlossaryTermRef> who cannot receive other drugs or whose cancer did not respond to other drugs, including <GlossaryTermRef href="CDR0000044893" dictionary="Cancer.gov" audience="Patient">imatinib mesylate</GlossaryTermRef>.</ListItem></ItemizedList></ListItem></ItemizedList><Para id="_3">Dasatinib is also being studied in the treatment of other types of cancer.</Para>                          
 </Section><Section id="_About"><Title>More About Dasatinib</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/315885">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.17">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a607063.html">Dasatinib</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.18"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.19">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Cancer Therapies</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C38713">Find Clinical Trials for Dasatinib</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2006-10-05</DateFirstPublished><DateLastModified>2022-09-01</DateLastModified></DrugInformationSummary>
